Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Arrive AI Inc.ARAI · Entity 7895 | Director | October 02, 2026 | October 09, 2026 |
| CVS HEALTH CorpCVS · Entity 2884 | Director | May 14, 2026 | May 15, 2026 |
| Elevance Health, Inc.ELV · Entity 2934 | EVP & Chief Financial Officer | March 01, 2023 | March 03, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Arrive AI Inc.
Report date October 02, 2026 · Filed October 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock AwardSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 172,811 |
Reported balance
After 2026-10-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-10-02 · Grant · Acquired 172,811 · Balance 172,811 F1: Restricted Stock Units (RSUs) were granted on October 2, 2026, which vest on September 30, 2027. The RSUs have been issued pursuant to the Company's 2023 Equity Incentive Plan. F2: The RSUs do not expire, they either vest or are canceled prior to the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock Units (RSUs) were granted on October 2, 2026, which vest on September 30, 2027. The RSUs have been issued pursuant to the Company's 2023 Equity Incentive Plan.
F2: The RSUs do not expire, they either vest or are canceled prior to the vesting date.
CVS HEALTH Corp
Report date May 14, 2026 · Filed May 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 1,447.5039 |
Reported balance
After 2026-05-14 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-14 · Grant · Acquired 1,447.5039 · Balance 1,447.5039 F1: Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan. F2: Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan.
F2: Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person.
Elevance Health, Inc.
Report date March 01, 2023 · Filed March 03, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 63,725 |
Ending reported balance
After 2023-03-02 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2023-03-01 · Tax withholding · Disposed 587 · Balance 55,594 F1: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Row 2 · 2023-03-01 · Grant · Acquired 3,065 · Balance 58,659 F2: Represents restricted share units. Restrictions lapse as follows: 1,021 shares on 3/1/2024, and 1,022 shares each on 3/1/2025 and 3/1/2026. Row 3 · 2023-03-01 · Grant · Acquired 9,716 · Balance 68,375 F3: Represents performance based restricted share units. Restrictions lapse on 3/2/2023. Row 4 · 2023-03-02 · Tax withholding · Disposed 4,650 · Balance 63,725 F1: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $469.03 · Expires 2033-03-01 | Direct | 11,782 |
Reported balance
After 2023-03-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2023-03-01 · Grant · Acquired 11,782 · Balance 11,782 F4: The option represents a right to purchase a total of 11,782 shares, and is exercisable in two installments of 3,927 shares each and one installment of 3,928 shares, beginning on 3/1/2024, which is the one-year anniversary of the option grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2: Represents restricted share units. Restrictions lapse as follows: 1,021 shares on 3/1/2024, and 1,022 shares each on 3/1/2025 and 3/1/2026.
F3: Represents performance based restricted share units. Restrictions lapse on 3/2/2023.
F4: The option represents a right to purchase a total of 11,782 shares, and is exercisable in two installments of 3,927 shares each and one installment of 3,928 shares, beginning on 3/1/2024, which is the one-year anniversary of the option grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 02, 2026 Filed Oct 9, 2026 21:20 UTC | Arrive AI Inc. ARAI · Entity 7895 | GrantRestricted Stock Award · Derivative | 172,811 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-046605 · ownership.xml · derivative · entry 1 Gallina John E · CIK 0001433032 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,811 Underlying: Common Stock · 172,811 shares Expires not disclosed F1 · derivative.exercise_date: Restricted Stock Units (RSUs) were granted on October 2, 2026, which vest on September 30, 2027. The RSUs have been issued pursuant to the Company's 2023 Equity Incentive Plan. F2 · derivative.expiration_date: The RSUs do not expire, they either vest or are canceled prior to the vesting date. Read SEC document |
| July 06, 2026 Filed Jul 7, 2026 20:23 UTC | Arrive AI Inc. ARAI · Entity 7895 | GrantRestricted Stock Award · Derivative | 87,413 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-032334 · ownership.xml · derivative · entry 1 Gallina John E · CIK 0001433032 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,413 Underlying: Common Stock · 87,413 shares Expires not disclosed F1 · derivative.exercise_date: Restricted Stock Units (RSUs) were granted on July 6, 2026, which vest on June 30, 2027. The RSUs have been issued pursuant to the Company's 2023 Equity Incentive Plan. F2 · derivative.expiration_date: The RSUs do not expire, they either vest or are canceled prior to vesting date. Read SEC document |
| May 14, 2026 Filed May 15, 2026 21:25 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantDeferred Stock Units · Derivative | 1,447.5039 | $97.15 Strike: $0.00 | $140,625.00 |
DisclosureSEC source: 0000064803-26-000080 · form4.xml · derivative · entry 1 Gallina John E · CIK 0001433032 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,447.5039 Underlying: Common Stock · 1,447.5039 shares Expires not disclosed F1 · kind: Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person. F2 · derivative.expiration_date: Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:05 UTC | Arrive AI Inc. ARAI · Entity 7895 | GrantRestricted Stock Award · Derivative | 47,052 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-014906 · ownership.xml · derivative · entry 1 Gallina John E · CIK 0001433032 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,052 Underlying: Common Stock · 47,052 shares Expires not disclosed F1 · derivative.exercise_date: Restricted Stock Units (RSUs) were granted on March 31, 2026, which vest on March 31, 2027. The RSUs have been issued pursuant to the Company's 2023 Equity Incentive Plan. F2 · derivative.expiration_date: The RSUs do not expire, they either vest or are canceled prior to vesting date. Read SEC document |
| March 19, 2026 Filed Mar 20, 2026 21:05 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 582 | $71.86 | $41,822.52 |
DisclosureSEC source: 0000064803-26-000022 · form4.xml · nonDerivative · entry 1 Gallina John E · CIK 0001433032 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 582 F1 · kind: Consists of common stock issued in payment of a pro rata semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 22:15 UTC | Arrive AI Inc. ARAI · Entity 7895 | GrantRestricted Stock Award · Derivative | 14,259 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-000431 · ownership.xml · derivative · entry 1 Gallina John E · CIK 0001433032 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,551 Underlying: Common Stock · 14,259 shares Expires not disclosed F1 · derivative.exercise_date: Restricted Stock Units (RSUs) were granted on December 31, 2025, which vest on December 30, 2026. The RSUs have been issued pursuant to the Company's 2023 Equity Incentive Plan. F2 · derivative.expiration_date: The RSUs do not expire, they either vest or are canceled prior to vesting date. Read SEC document |
| October 06, 2025 Filed Oct 8, 2025 20:21 UTC | Arrive AI Inc. ARAI · Entity 7895 | GrantCommon Stock | 7,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-017430 · ownership.xml · nonDerivative · entry 1 Gallina John E · CIK 0001433032 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,202 F1 · shares: These shares were issued to the Reporting Person for his service to the Issuer's board of directors in 2025, in return for $0.00 in consideration. Read SEC document |
| October 06, 2025 Filed Oct 20, 2025 20:48 UTC Amendment | Arrive AI Inc. ARAI · Entity 7895 | GrantRestricted Stock Award · Derivative | 7,292 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-018657 · ownership.xml · derivative · entry 1 Gallina John E · CIK 0001433032 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,292 Underlying: Common Stock · 7,292 shares Expires not disclosed F1 · derivative.exercise_date: Restricted Stock Units (RSUs) were granted on October 6, 2025, which vest on September 30, 2026. The RSUs have been issued pursuant to the Company's 2023 Equity Incentive Plan. F2 · derivative.expiration_date: The RSUs do not expire, they either vest or are canceled prior to vesting date. Read SEC document |
| June 30, 2025 Filed Sep 4, 2025 00:44 UTC | Arrive AI Inc. ARAI · Entity 7895 | GrantCommon Stock | 856 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-026490 · ownership.xml · nonDerivative · entry 2 Gallina John E · CIK 0001433032 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,910 F1 · shares: These shares were issued to the Reporting Person for his service to the Issuer's board of directors in 2025, in return for $0.00 in consideration. Read SEC document |
| June 23, 2025 Filed Sep 4, 2025 00:44 UTC | Arrive AI Inc. ARAI · Entity 7895 | GrantCommon Stock | 7,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-026490 · ownership.xml · nonDerivative · entry 1 Gallina John E · CIK 0001433032 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,054 F1 · shares: These shares were issued to the Reporting Person for his service to the Issuer's board of directors in 2025, in return for $0.00 in consideration. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:15 UTC | Elevance Health, Inc. ELV · Entity 2934 | Tax withholdingCommon Stock | 4,650 | $468.78 | $2,179,827.00 |
DisclosureSEC source: 0001156039-23-000025 · wf-form4_167787809281315.xml · nonDerivative · entry 4 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,725 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:15 UTC | Elevance Health, Inc. ELV · Entity 2934 | GrantEmployee Stock Option (Right to Buy) · Derivative | 11,782 | $0.00 Strike: $469.03 | $0.00 |
DisclosureSEC source: 0001156039-23-000025 · wf-form4_167787809281315.xml · derivative · entry 5 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,782 Underlying: Common Stock · 11,782 shares Expires 2033-03-01 F4 · derivative.exercise_date: The option represents a right to purchase a total of 11,782 shares, and is exercisable in two installments of 3,927 shares each and one installment of 3,928 shares, beginning on 3/1/2024, which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:15 UTC | Elevance Health, Inc. ELV · Entity 2934 | GrantCommon Stock | 9,716 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-23-000025 · wf-form4_167787809281315.xml · nonDerivative · entry 3 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,375 F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/2/2023. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:15 UTC | Elevance Health, Inc. ELV · Entity 2934 | GrantCommon Stock | 3,065 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-23-000025 · wf-form4_167787809281315.xml · nonDerivative · entry 2 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,659 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 1,021 shares on 3/1/2024, and 1,022 shares each on 3/1/2025 and 3/1/2026. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:15 UTC | Elevance Health, Inc. ELV · Entity 2934 | Tax withholdingCommon Stock | 587 | $469.03 | $275,320.61 |
DisclosureSEC source: 0001156039-23-000025 · wf-form4_167787809281315.xml · nonDerivative · entry 1 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,594 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 21:45 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GiftCommon Stock | 1,420 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-22-000024 · wf-form4_164634390386028.xml · nonDerivative · entry 5 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,181 Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 21:45 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 413 | $463.49 | $191,421.37 |
DisclosureSEC source: 0001156039-22-000024 · wf-form4_164634390386028.xml · nonDerivative · entry 4 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,601 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:45 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantEmployee Stock Option (Right to Buy) · Derivative | 11,594 | $0.00 Strike: $451.50 | $0.00 |
DisclosureSEC source: 0001156039-22-000024 · wf-form4_164634390386028.xml · derivative · entry 6 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,594 Underlying: Common Stock · 11,594 shares Expires 2032-03-01 F4 · derivative.exercise_date: The option represents a right to purchase a total of 11,594 shares, and is exercisable in three annual installments, with one installment of 3,864 shares and two installments of 3,865 shares each, beginning on 3/1/2023, which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:45 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 8,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-22-000024 · wf-form4_164634390386028.xml · nonDerivative · entry 3 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,014 F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/1/2022. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:45 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 2,907 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-22-000024 · wf-form4_164634390386028.xml · nonDerivative · entry 2 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,764 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 969 shares each on 3/1/2023, 3/1/2024 and 3/1/2025. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:45 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 4,162 | $451.50 | $1,879,143.00 |
DisclosureSEC source: 0001156039-22-000024 · wf-form4_164634390386028.xml · nonDerivative · entry 1 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,857 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| May 25, 2021 Filed May 26, 2021 20:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GiftCommon Stock | 3,301 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-21-000050 · wf-form4_162206103641936.xml · nonDerivative · entry 11 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,019 Read SEC document |
| May 24, 2021 Filed May 26, 2021 20:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 14,761 | $0.00 Strike: $232.04 | $0.00 |
DisclosureSEC source: 0001156039-21-000050 · wf-form4_162206103641936.xml · derivative · entry 16 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,761 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: The option represents a right to purchase a total of 14,761 shares and is exercisable in six semi-annual installments, with five installments of 2,460 shares each and one installment of 2,461 shares beginning on September 1, 2018, which is the six-month anniversary of the date on which the option was granted. Read SEC document |
| May 24, 2021 Filed May 26, 2021 20:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 19,908 | $0.00 Strike: $166.97 | $0.00 |
DisclosureSEC source: 0001156039-21-000050 · wf-form4_162206103641936.xml · derivative · entry 15 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,908 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The option represents a right to purchase a total of 19,908 shares and is exercisable in six semi-annual installments of 3,318 shares each beginning on September 1, 2017, which is the six-month anniversary of the date on which the option was granted. Read SEC document |
| May 24, 2021 Filed May 26, 2021 20:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 4,038 | $0.00 Strike: $132.51 | $0.00 |
DisclosureSEC source: 0001156039-21-000050 · wf-form4_162206103641936.xml · derivative · entry 14 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,038 shares Expires 2026-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The option represents a right to purchase a total of 8,074 shares and is exercisable in six semi-annual installments, with two installments of 1,345 shares each and four installments of 1,346 shares each beginning on December 1, 2016, which is the six-month anniversary of the date on which the option was granted. Read SEC document |
| May 24, 2021 Filed May 26, 2021 20:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,962 | $0.00 Strike: $131.80 | $0.00 |
DisclosureSEC source: 0001156039-21-000050 · wf-form4_162206103641936.xml · derivative · entry 13 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,962 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option represents a right to purchase a total of 5,883 shares and is exercisable in six semi-annual installments, with three installments of 980 shares each and three installments of 981 shares each beginning on September 1, 2016, which is the six-month anniversary of the date on which the option was granted. Read SEC document |
| May 24, 2021 Filed May 26, 2021 20:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,775 | $0.00 Strike: $146.93 | $0.00 |
DisclosureSEC source: 0001156039-21-000050 · wf-form4_162206103641936.xml · derivative · entry 12 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,775 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option represents a right to purchase a total of 5,775 shares and is exercisable in six semi-annual installments, with three installments of 962 shares each and three installments of 963 shares each beginning on September 2, 2015, which is the six-month anniversary of the date on which the option was granted. Read SEC document |
| May 24, 2021 Filed May 26, 2021 20:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 4,100 | $397.91 | $1,631,431.00 |
DisclosureSEC source: 0001156039-21-000050 · wf-form4_162206103641936.xml · nonDerivative · entry 10 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,320 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 22, 2021. F6 · price: This transaction was executed in multiple trades at prices ranging from $397.50 to $398.39. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 24, 2021 Filed May 26, 2021 20:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 1,100 | $396.50 | $436,150.00 |
DisclosureSEC source: 0001156039-21-000050 · wf-form4_162206103641936.xml · nonDerivative · entry 9 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,420 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 22, 2021. F5 · price: This transaction was executed in multiple trades at prices ranging from $396.23 to $396.56. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 24, 2021 Filed May 26, 2021 20:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 15,262 | $395.67 | $6,038,715.54 |
DisclosureSEC source: 0001156039-21-000050 · wf-form4_162206103641936.xml · nonDerivative · entry 8 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,520 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 22, 2021. F4 · price: This transaction was executed in multiple trades at prices ranging from $395.23 to $396.17. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 24, 2021 Filed May 26, 2021 20:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 8,163 | $394.62 | $3,221,283.06 |
DisclosureSEC source: 0001156039-21-000050 · wf-form4_162206103641936.xml · nonDerivative · entry 7 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,782 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 22, 2021. F3 · price: This transaction was executed in multiple trades at prices ranging from $394.18 to $395.17. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 24, 2021 Filed May 26, 2021 20:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 17,819 | $393.56 | $7,012,845.64 |
DisclosureSEC source: 0001156039-21-000050 · wf-form4_162206103641936.xml · nonDerivative · entry 6 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,945 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 22, 2021. F2 · price: This transaction was executed in multiple trades at prices ranging from $393.17 to $394.16. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 24, 2021 Filed May 26, 2021 20:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 14,761 | $232.04 | $3,425,142.44 |
DisclosureSEC source: 0001156039-21-000050 · wf-form4_162206103641936.xml · nonDerivative · entry 5 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,764 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2021 Filed May 26, 2021 20:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 19,908 | $166.97 | $3,324,038.76 |
DisclosureSEC source: 0001156039-21-000050 · wf-form4_162206103641936.xml · nonDerivative · entry 4 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,003 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2021 Filed May 26, 2021 20:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 4,038 | $132.51 | $535,075.38 |
DisclosureSEC source: 0001156039-21-000050 · wf-form4_162206103641936.xml · nonDerivative · entry 3 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2021 Filed May 26, 2021 20:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 1,962 | $131.80 | $258,591.60 |
DisclosureSEC source: 0001156039-21-000050 · wf-form4_162206103641936.xml · nonDerivative · entry 2 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2021 Filed May 26, 2021 20:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 5,775 | $146.93 | $848,520.75 |
DisclosureSEC source: 0001156039-21-000050 · wf-form4_162206103641936.xml · nonDerivative · entry 1 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 21:35 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 483 | $311.66 | $150,531.78 |
DisclosureSEC source: 0001156039-21-000030 · wf-form4_161480728684695.xml · nonDerivative · entry 4 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,320 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:35 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantEmployee Stock Option (Right to Buy) · Derivative | 12,357 | $0.00 Strike: $311.48 | $0.00 |
DisclosureSEC source: 0001156039-21-000030 · wf-form4_161480728684695.xml · derivative · entry 5 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,357 Underlying: Common Stock · 12,357 shares Expires 2031-03-01 F4 · derivative.exercise_date: The option represents a right to purchase a total of 12,357 shares, and is exercisable in three annual installments of 4,119 shares each, beginning on 3/1/2022, which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:35 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 23,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-21-000030 · wf-form4_161480728684695.xml · nonDerivative · entry 3 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,803 F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/1/2021. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:35 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 3,010 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-21-000030 · wf-form4_161480728684695.xml · nonDerivative · entry 2 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,581 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 1,003 shares each on 3/1/2022 and 3/1/2023, and 1,004 on 3/1/2024. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:35 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 10,633 | $311.48 | $3,311,966.84 |
DisclosureSEC source: 0001156039-21-000030 · wf-form4_161480728684695.xml · nonDerivative · entry 1 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,571 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 21:32 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GiftCommon Stock | 2,589 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-20-000103 · wf-form4_160763591286113.xml · nonDerivative · entry 1 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,204 Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:44 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantEmployee Stock Option (Right to Buy) · Derivative | 15,926 | $0.00 Strike: $271.27 | $0.00 |
DisclosureSEC source: 0001127602-20-009441 · form4.xml · derivative · entry 4 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,926 Underlying: Common Stock · 15,926 shares Expires 2030-03-02 F4 · derivative.exercise_date: The option represents a right to purchase a total of 15,926 shares, and is exercisable in three annual installments, with one installment of 5,308 shares and two installments of 5,309 shares each, beginning on 3/2/2021, which is the one-year anniversary of the option grant date. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:44 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 37,420 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009441 · form4.xml · nonDerivative · entry 3 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,793 F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/2/2020. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:44 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 2,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009441 · form4.xml · nonDerivative · entry 2 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,373 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 998 shares on 3/2/2021, and 999 shares each on 3/2/2022 and 3/2/2023. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:44 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 17,374 | $271.27 | $4,713,044.98 |
DisclosureSEC source: 0001127602-20-009441 · form4.xml · nonDerivative · entry 1 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,377 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 20:44 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 2,033 | $276.44 | $562,002.52 |
DisclosureSEC source: 0001127602-19-020730 · form4.xml · nonDerivative · entry 2 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,751 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 20, 2019 Filed Jun 4, 2019 20:44 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GiftCommon Stock | 2,272 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020730 · form4.xml · nonDerivative · entry 1 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,784 Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:08 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantEmployee Stock Option (Right to Buy) · Derivative | 12,187 | $0.00 Strike: $307.68 | $0.00 |
DisclosureSEC source: 0001127602-19-009899 · form4.xml · derivative · entry 5 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,187 Underlying: Common Stock · 12,187 shares Expires 2029-03-01 F5 · derivative.exercise_date: The option represents a right to purchase a total of 12,187 shares, and is exercisable in three annual installments, with two installments of 4,062 shares each and one installment of 4,063 shares, beginning on 3/1/2020, which is the one-year anniversary of the option grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.